Vaccheri A, Dall'Olio R, Gandolfi O, Montanaro N
Psychopharmacology (Berl). 1986;89(3):265-8. doi: 10.1007/BF00174356.
A critical dose of apomorphine (300 micrograms/kg SC) given immediately before placing rats into a novel environment produced a diphasic motility response (initial sedation followed by enhanced locomotion). Various neuroleptics having different clinical and/or pharmacological profiles were studied by using such a model. (-)-Sulpiride and sultopride preferentially antagonized apomorphine inhibition; haloperidol and tiapride antagonized both phases of apomorphine response at similar doses; chlorpromazine, fluphenazine, thioridazine, metoclopramide and SCH 23390 preferentially antagonized apomorphine stimulation. The results are discussed in terms of the dopamine receptor subtypes involved in the two phases of apomorphine effect. Apomorphine stimulation can be antagonized by D-1 as well as D-2 receptor blockade. A higher affinity for D-2 receptors seems a necessary requisite for the antagonism of apomorphine inhibition; moreover, the ability of neuroleptics to antagonize apomorphine inhibition seems to depend on the ratio of their presynaptic versus postsynaptic D-2 activity.
在将大鼠放入新环境之前立即给予临界剂量的阿扑吗啡(300微克/千克,皮下注射)会产生双相运动反应(最初镇静,随后运动增强)。利用这样的模型研究了具有不同临床和/或药理学特征的各种抗精神病药物。(-)-舒必利和舒托必利优先拮抗阿扑吗啡的抑制作用;氟哌啶醇和硫必利在相似剂量下拮抗阿扑吗啡反应的两个阶段;氯丙嗪、氟奋乃静、硫利达嗪、甲氧氯普胺和SCH 23390优先拮抗阿扑吗啡的兴奋作用。根据参与阿扑吗啡效应两个阶段的多巴胺受体亚型对结果进行了讨论。阿扑吗啡的兴奋作用可被D-1以及D-2受体阻断所拮抗。对D-2受体具有更高亲和力似乎是拮抗阿扑吗啡抑制作用的必要条件;此外,抗精神病药物拮抗阿扑吗啡抑制作用的能力似乎取决于它们突触前与突触后D-2活性的比例。